skip to Global Navigation Bar skip to main content

homeHome > R&D > Major Research Achievements

 Major Research Achievements

  • Nabota
  • Olostar
  • Daewoong EGF
  • Luphere
  • Ursa
  • Albis
  • Moxicle


Albis pic


Albis is a new antiulcer combination drug that treats gastroduodenal ulceration by inhibiting aggressive factors and boosting defensive factors. The drug represents an ideal mix of ranitidine, which inhibits the secretion of gastric acid, sucralfate, which protects mucous membrane, and bismuth, which suppresses Helicobacter pylori.


A new combination drug patented as cored tablets coated with ranitidine and wrapped with the mix of bismuth and sucralfate, in order to prevent sucralfate from compromising the absorption of ranitidine in the simultaneous administration of the three components.

[Reg. patent KR0453179]


Gastric ulcer, gastritis, duodenal ulcer, Zollinger-Ellison syndrome, reflux oesophagitis, preanesthetic medication (to prevent Mandelson's syndrome), postoperative ulcer, gastroduodenal ulceration from non-steroidal anti-inflammatory analgesic drug (NSAID)

  • Albis Tab